Tumor sidedness and enriched gene groups for efficacy of first-line cetuximab treatment in metastatic colorectal cancer
Sunakawa, Y., et al. Tumor sidedness and enriched gene groups for efficacy of first-line cetuximab treatment in metastatic colorectal cancer. Mol Cancer Ther. 2018 Oct 1. pii. molcanther.0694.2018. doi: 10.1158/1535-7163.MCT-18-0694 [Epub ahead of print]